MENU
VRCA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Verrica Pharmaceuticals (VRCA) Earnings Date & Reports
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
VRCA is expected to report earnings to fall 19.35% to -50 cents per share on November 13
Q3'26
Est.
$-0.50
Q2'26
Missed
by $0.22
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.51
Q3'25
Beat
by $0.21
The last earnings report on August 06 showed earnings per share of -62 cents, missing the estimate of -39 cents. With 16.72K shares outstanding, the current market capitalization sits at 59.61M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
44 West Gay Street
Phone
+1 484 453-3300
Employees
76
Web
https://www.verrica.com